|
-
andrepharma3
2025-3-14
-
105
0
|
|
-
andrepharma3
2025-3-14
-
97
0
|
|
-
andrepharma3
2025-3-14
-
94
0
|
|
-
andrepharma3
2025-3-14
-
96
0
|
|
-
andrepharma3
2025-3-14
-
87
0
|
|
-
andrepharma3
2025-3-14
-
101
0
|
|
-
andrepharma3
2025-3-14
-
104
0
|
|
-
andrepharma3
2025-3-14
-
98
0
|
|
-
andrepharma3
2025-3-14
-
97
0
|
|
-
andrepharma3
2025-3-14
-
114
0
|
|
-
andrepharma3
2025-3-14
-
100
0
|
|
-
andrepharma3
2025-3-14
-
104
0
|
|
-
andrepharma3
2025-3-14
-
107
0
|
|
-
andrepharma3
2025-3-14
-
92
0
|
|
-
andrepharma3
2025-3-14
-
92
0
|
|
-
andrepharma3
2025-3-14
-
110
0
|
|
-
andrepharma3
2025-3-14
-
95
0
|
|
-
andrepharma3
2025-3-14
-
105
0
|
|
-
andrepharma3
2025-3-14
-
107
0
|
|
-
andrepharma3
2025-3-14
-
123
0
|